Raymond James Financial’s Transmedics TMDX Stock Holding History

Raymond James Financial’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1M	Buy	115,035 +2,503	+2%	+$326K	﹤0.01%	1931
2025 Q4	$13.7M	Sell	112,532 -448	-0.4%	-$56.2K	﹤0.01%	1721
2025 Q3	$12.7M	Sell	112,980 -78,369	-41%	-$9.17M	﹤0.01%	1742
2025 Q2	$25.6M	Buy	191,349 +45,956	+32%	+$5.05M	0.01%	1178
2025 Q1	$9.78M	Buy	145,393 +83,722	+136%	+$5.76M	﹤0.01%	1827
2024 Q4	$3.85M	Buy	+61,671	New	+$5.74M	﹤0.01%	2485

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's TMDX Position: Q1 2026 in Review

Raymond James Financial increased its Transmedics (TMDX) stake by 2.2% in Q1 2026, buying an estimated $326K and bringing the position to 115,035 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Raymond James Financial first reported a position in TMDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $25.6M in Q2 2025. 415 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Raymond James Financial held 115,035 shares of Transmedics worth $11.1M as of Q1 2026.
Raymond James Financial bought 2,503 Transmedics shares in Q1 2026, an estimated $326K.
Transmedics made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1931 holding.
Raymond James Financial first reported a position in Transmedics in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's Transmedics position peaked at $25.6M in Q2 2025.
415 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.